Analysis of Erythromycin II. Determination of Erythromycin in Human Blood Serum by Competitive Displacement of [14C]-Erythromycin from E. Coli Ribosomes

Abstract

A sensitive and selective method for the determination of erythromycin in human blood serum, in the range of 0.1 to 1.0 μg/ml, is described. The procedure is based on extraction of drug into ether and competitive displacement of [¹⁴C]-erythromycin from E. coli ribosomes. The method provides accurate, precise and rapid analyses and should be readily adaptable to bioavailability studies with erythromycin and its salts in man.     

Assay of Erythromycin from Human Serum by High Performance Liquid Chromatography with Electrochemical Detection

Abstract

A sensitive and selective method has been developed for the determination of serum concentrations of erythromycin A by high performance liquid chromatography with electrochemical detection. Erythromycin was extracted from alkalinized serum samples with methyl t-butyl ether. After evaporation of the ether, the samples were reconstituted in acetonitrile/ammonium acetate and washed with hexane. Aliquots were injected onto a Sepralyte diphenyl column. The mobile phase consists of acetonitrile/sodium perchlorate/ammonium acetate/methanol under isocratic conditions. Eluted peaks were detected by dual coulometric electrodes operated in the oxidative screen mode. The recovery of erythromycin from serum was 84%. Assay limit of quantification was 0.05 μg/ml serum, and dynamic linear range was 0.05–1.5 μg/ml. This method was used to quantitate both erythromycin and its gastric degradation products from human serum. Additionally, other macrolide antibiotics could be quantified by electrochemical detection. Analytical results for erythromycin compared favorably with those obtained with a standard microbiological assay.     

A Validated Ion-Pairing High Performance Liquid Chromatographic Method for the Determination of Enoxacin and its Metabolite Oxo-Enoxacin in Plasma and Urine

Abstract

A rapid, sensitive, and specific determination of enoxacin and its principal metabolite, oxo-enoxacin, in plasma and urine is described. the method, which employs the structurally related compound ciprof loxac in as internal standard, involves a protein precipitation step for plasma and solid-phase extraction for urine. Liquid chromatographic analysis is carried out on a C-18 bonded silica column; the mobile phase consists of 0.1 M citric-acid/acetonitrile employing ammonium perchlorate and tetrabutyl-ammonium hydroxide as ion-pairing agents. Quantitation is performed by UV-detection at 340 nm.

The analytical method was validated by examining the performance characteristics specificity, linearity, precision, accuracy, sensitivity, and recovery. Enoxacin calibration curves were linear between 0.02 and 3.2 μg/ml of plasma and from 0.5 to 125 μg/ml of urine. Limits of quantitation in plasma and urine were 0.01 and 0.5 μg/ml, respectively. For oxo-enoxacin, linear of calibration curves were obtained i n the range 0.05 to 1.6 μg/ml (plasma) and 1 to 50 μg/ml (urine); the respective quantitation limits were approximately 0.02 and 1 μg/ml.

The present assay procedure has been applied to monitoring plasma and urine concentrations in several pharmacokinetic studies in humans and different animal species.     

An HPLC Method for the Determination of Theophylline and Its Metabolites in Serum and Urine

Abstract

A urine and a serum assay have been developed to quantitate theophylline and its major metabolites:1,3-dimethyluric acid, 3-methylxanthine and 1-methyluric acid. Reverse phase chromatography follows a serum acetone extraction procedure and a urine anion exchange clean-up procedure. Lower limits of sensitivity are 0.04 μg/ml for serum metabolites and 1 μg/ml for urine metabolites. Both assays are free of interference from endogenous substances. These assays have been tested successfully in pharmacokinetic and metabolic studies of theophylline.     

High-Pressure Liquid Chrohatographic Assay of Cefotaxime and Desacetylcefotaxime in Human Myometrium

Abstract

An analytic high-pressure liquid chromatographic (HPLC) procedure for the assay of desacetylcefotaxime and cefotaxime in gynecologic tissue was developed. Normal individuals undergoing elective hysterectomy were subjects in this study. Blood and myometrium were removed up to four hours after a 1-g intramuscular dose of cefotaxime. Since cefotaxime is unstable in homogenized tissue at room temperature, the specimens must be maintained at 4°C during homogenization and extraction. Mean serum desacetylcefotaxime and cefotaxime levels were 3.2 ± 2.0 μg/ml and 6.8 ± 4.4 μ/ml, respectively. The mean myometrium concentrations of desacetylcefotaxime and cefotaxime were 8.4 ± 10.0 μg/g and 6.3 ± 8.9 μg/g, respectively. The cefotaxime to desacetylcefotaxime ratios in serum and tissue were 2.12 and 0.75, respectively. Our results suggest that in antimicrobial synergistic studies evaluating serum and tissue levels, the optimal ratio of one part cefotaxime to at least one part desacetylcefotaxime.     

Fluorigenic Derivatization of Oxazepam. Application to Its Determination in Pharmaceuticals

Abstract

Oxazepam, when heated in mixtures of acetic acid and methanol, undergoes a reaction giving an intense fluorescence at excitation and emission wavelengths of 364 and 469 nm, respectively. The best reaction conditions were a 7:25 methanol:acetic acid volume ratio, a temperature of 100 °C (examinated range 50–100 °C), and a reaction time of 5 minutes. A linear range from 0.025 to 50 μg/ml with a limit of detection of 0.014 μg/ml and a reproducibility within day of less than 5% were attained. A Flow Injection Analysis method was designed and a linear range from 0.1 to 100 μg/ml with a limit of detection of 0.035 μg/ml and a reproducibility within day of less than 5% were obtained. These methods were applied to the determination of oxazepam in five pharmaceutical formulations.     

High Performance Liquid Chromatographic Analysis of Cepoperazone in Serum and Urine

Abstract

A high performance liquid chromatographic method was developed for the quantitative analysis of cefoperazone in serum and urine. Standard curves were linear over the range of concentrations 2–30 μg/ml and a good correlation was established between the amount of cefoperazone injected and peak height. The mean percentage analytical recovery of cefoperazone was 96.3% and the mean within day coefficient of variation in serum was 2.8%. Serum and urine components, as well as several beta-lactam antibiotics, did not interfere with the measurement of cefoperazone. This is a rapid, reproducible, and sensitive assay suitable for use in pharmacokinetic studies.     

A Simple Electrochemical Method for the Quantitative Determination of Acetaminophen in Serum

Abstract

A simple electrochemical method for the determination of acetaminophen in serum is described. The eleotrode and associated electronics are simple, reliable, and inexpensive to build. The apparatus can be operated at a rate of 2–3 determinations per minute using only 10 μl serum per determination. The procedure includes extraction of acetaminophen in ethyl acetate and subsequent oxidative amperometric detection of the drug by a form of flow-injection analysis. The system parameters of buffer, pH, and redox potential have been optimized to permit measurement of less than 10 μg/ml of acetaminophen. The determination is linear over the range of 10–300 μg/ml with a C.V. of less than 3% for replicate analysis of the same sample.     

Solvent Donicity Influence in the Fluorescence Emission of the Lithium/1,4-Dihydroxyanthraquinone System. Improvement in the Quantification of Lithium.

Abstract

The fluorescence emission from the lithium/1,4-dihydroxyanthraquinone system shows a great enhancement in the presence of certain water-miscible solvents. This is justified from the donicity (nucleophilic properties) of the solvent that facilitates the solvation of the lithium cation in solution and the stabilization of an nondissociated ion-pair between the solvated lithium cation and the 1,4-dihydroxyanthraquinonate anion. A very sensitive analytical method was proposed for the spectrofluorimetric determination of lithium based on its reaction with 1,4-dihydroxyanthraquinone (quinizarin) in a dimethylsulfoxide medium (90%) and in presence of sodium hydroxide. The fluorescence is measured at an excitation wavelength of 602 nm and an emission wavelength of 670 nm and it is stable at 25°C at least 6 h. The calibration curve is linear over the concentration ranges of 2–40 μg/l of lithium in an aqueous matrix and 3–50 μg/l in a serum matrix; the RSD's in the determination of 20 μg/l of Li⁺ were 2.6% and 3.2%, respectively. The proposed procedure was satisfactorily applied to the determination of lithium in drugs, dietetic products and human serum.     

Semiquantitative and Quantitative Determination of Trace Amount of Phosphate Ion in Water Using Polyurethane Foam Thin -Layer Colorimetry

Abstract

A simple, sensitive and fast method for the colorimetric determination of phosphate ion in water is described.

The method is based on spectrophotometric measurement of the blue molybdoantimony phosphoric acid species sorbed in a polyurethane foam thin-layer for quantitative determination of phosphate ion, or the visual color comparison technique for rapid semiquantitative determination.

The detection limit for the quantitative procedure is 5 μg/1 and for semiquantitative procedure 20 μg/1 for sample volumes of 100 ml and 25 ml, respectively.     

Second Derivative Ultraviolet Spectrophotometry and High Performance Liquid Chromatography with Fluorometric Detection of Cycloserine Using 9-Chloro-10-methyl Acridinium Triflate as a New UV and Fluorescent Labeling Agent

Abstract

Sensitive and simple second derivative UV spectrophotometric and HPLC with fluorometric detection methods were developed for cycloserine based on derivatization with 9-chloro-10-methyl acridinium triflate (CMAT) to yield a reaction product which absorbs in the UV at 361 nm and is fluorescent using excitation and emission wavelengths of 257 nm and 475 nm, respectively. The CMAT derivatization reaction takes 30 minutes at 70°C. Cycloserine was linear in the 0.3 – 5.0 μg/ml range (r=0.999, n=5) for the second derivative UV method and the 0.8 – 5 μg/ml range for the HPLC method (r=0.999, n=5). The limit of detection for cycloserine in the HPLC method can be improved to 0.15 μg/ml with the addition of glacial acetic acid to the analytical sample. The HPLC assay was applied to the determination of cycloserine in spiked human urine samples. The correlation coefficient (r) was in the 0.999 range and sensitivity was at the low pg/ml level.     

Determination of the New Ace-Inhibitor Quinapril and Its Active Metabolite Quinaprilate in Plasma and Urine by High-Performance Liquid Chromatography and Pre-Column Labelling for Fluorescent-Detection

Abstract

A sensitive and selective method for the determination of quinapril and its active metabolite quinaprilate in human plasma and urine is described. The method is based on isolation using C18 Bond Elut cartridges, pre-column derivatization with 9-anthryldiazo-methane and purification of the reaction mixture on CBA columns followed by reversed-phase high performance liquid chromatography with fluorometric detection. Calibration curves were linear between 20 ng and 1000 ng/ml of plasma (100-2000 ng for urine) for both substances, the lower limit of detection being 5-10 ng/ml.

The present assay procedure has been applied to monotoring plasma and urine concentrations in several pharmacokinetic studies in humans.     

High Pressure Liquid Chromatographic Determination of Mecillinam in Human Plasma and Urine

Abstract

A simple, specific, rapid and sensitive method for the analysis of mecillinam in plasma and urine using high pressure liquid chromatography is described. The assay is performed by direct injection of a plasma protein free supernatant or a dilution of urine. A μBondapak phenyl column with an eluting solvent of 16% CH₃CN-0.2% H₃PO₄ was used, with UV detection of the effluent at 220 nm. Desacetyl-cephalothin was used as the internal standard and quantitation was based on peak height ratio of mecillinam to that of the internal standard. The lowest concentration detectable without extraction was 0.25 μg/ml for plasma and 8.9 μg/ml for urine. No interference from plasma and urine was noted.     

HPLC Analysis of Cefmetazole and Nocardicins A and E in Human Serum and Urine Using Solid-Phase Extraction

Abstract

A method for extraction and quantification of cefmetazole and nocardicins A and E in serum and urine samples is described in this paper. Sample pretreatment is carried out using solid-phase extraction cartridges, resulting in very high extraction recoveries of these β-lactam antibiotics. The procedure, which prepares biological fluids for reversed-phase high-performance liquid chromatographic analysis is convenient, rapid and reproducible. An water-methanol-acetic acid mobile phase was used with benzotriazole as an internal standard. The detection limit was 0.2 μg/ml at 280 nm.     

Spectrophotometric Determination of Tetracyclines in Pure Form and in Pharmaceutical Preparations,by a Molybdenum Blue Method

Abstract

A new and sensitive spectrophotometric method has been developed for the determination of tetracyclines either in a pure form or in Pharmaceuticals, by a molybdenum blue method. The procedure is based on the observation that, in sulphuric acid medium, tetracyclines reduce ammonium molybdate to molybdenum blue, the absorbance of which is proportional to the amount of antibiotic present. The variables affecting development of the color have been investigated and the conditions optimized. Beer's law is obeyed for up to 20 μg/ml of tetracycline HCl and oxytetracycline HCl, 28 μg/ml of demeclocycline HCl, 18 μg/ml of chlortetracycline HCl, 32 μg/ml of doxycycline HCl and 40 μ/ml of rolitetracycline. Molar absorptivities (1 mol^?1 cm^?1) and Sandell's sensitivities (μ cm^?2 per 0.001 absorbance unit) are, respectively: tetracycline HCl 4.9×10⁴ and 0.0098, oxytetracycline HCl 5.4×10⁴ and 0.0092, demeclocycline HCl 1.6×10⁴ and 0.0313, chlortetracycline HCl 5.5×10⁴ and 0.0094, doxycycline HCl 3.4×10⁴ and 0.0141, rolitetracycline 2.7×10⁴ and 0.0195.     

A Simple Gas Chromatographic Method for the Measurement of Dichloroacetic Acid in Plasma or Urine

Abstract

A method has been developed for measurement of dichloroacetic acid in plasma or urine. The procedure is based on derivatization of dichloroacetic acid with methanol-boron trifluoride, extraction of the resulting methyl ester and gas chromatography. The method has good accuracy and precision, and can be used to determine concentrations as low as 0.04 μg/ml.     

Colorimetric Determination of Propofol in Bulk form,Dosage Form and Biological Fluids

ABSTRACT

Propofol is coupled with 2, 6-dichloroquinone-4-chlorimide (DCQ) in a reaction buffered at pH 9.6 to give a colored product having an analytically useful maximum at 635 nm. The factors affecting the color generation were optimized and incorporated in the procedure. The reacted propofol has a molar absorptivity of 3.9 × 10^?4 L mol^?1 cm^?1, and Beer's law is obeyed for concentrations 1-5 μg ml^?1 with detection limit 0.25 μg ml^?1. The method was found applicable to biological fluids (plasma and urine) spiked with propofol at concentration levels 1-5 μg ml^?1 for plasma and 1-5 μg 0.5 ml^?1 urine (less sensitivity is obtained with urine volumes above 0.5 ml) with detection limits 0.28 μg ml^?1 for plasma and 0.4 μg 0.5 ml^?1 urine. The average recovery for the commercial preparation (1% w/v propofol emulsion intravenous injection for infusion) was 99.54% with an RSD of 1.05%. The method was validated by an adopted HPLC method. The results obtained by the HPLC method for the commercial preparation were statistically compared with the proposed method and evaluated at the 95% confidence limits.     

A Fluorimetric Method for the Determination of Cyanide with Fluorescein and Iodine∗

Abstract

A rapid, simple and sensitive fluorimetric method has been developed for the determination of cyanide with fluorescein as fluorogenic reagent (λ_ex = 494 nm, λ_em = 514 nm) at pH 6.0–7.0. A linear calibration curve was obtained in the range 0.004–2.0 μg CN^?/25 ml. The detection limit is 0.004 μg CN^-/25 ml. The method was successfully applied to the determination of cyanide in waste water.

     

A Fluorimetric Method for the Determination of Atmospheric Sulphur Dioxide With 2′, 7′—Dichlorofluorescein∗

Abstract

A rapid, simple and sensitive fluorimetric method has been developed for the determination of atmospheric sulphur dioxide with dichlorofluorescein as fluorogenic reagent (λ_ex = 505 nm, λ_em = 520 nm) at pH 4.0–6.0. A linear calibration curve was obtained in the range 0.01–0.40 μg SO₂/25 ml. The detection limit is 0.01 μg SO₂/25 ml. Nitrogen dioxide does not interfere with the method. The method was successfully applied to the determination of atmospheric sulphur dioxide.

     

Fluorometric Determination of Chlorzoxazone via Chemical Derivatization

Abstract

Parameters for the fluorometric determination of chlorzoxazone based on chemical derivatization with various fluorogenic reagents is presented. Among the reagents utilized were dansyl chloride, fluorescamine, 2,4-dihydroxybenzaldehyde and salicylaldehyde. The reagents were reacted with either intact chlorzoxazone or with the o-aminophenol and semicarbazide derivatives formed by reaction of the drug with aqueous base and hydrazine hydrate, respectively. The fluorophor formed by basic hydrolysis of chlorzoxazone followed by reaction with fluorescarnine was the most sensitive procedure investigated. Fluorescence was linear over the range 0.27–3.4 μg/ml. Application of the procedure to the analysis of chlorzoxazone in a dosage form and in spiked human plasma and urine samples gave accuracy in the range 1–4%.